Skip to content
Top Globe News – Lifestyle
Author:
Aro Biotherapeutics
Aro Biotherapeutics Reports Therapeutic Potential of Centyrin–CD40 siRNA Conjugate for the Treatment of Inflammatory Myositis
November 10, 2026
Aro Biotherapeutics Reports Therapeutic Potential of Centyrin – IFIH1 siRNA Conjugate for the Treatment of Type 1 Diabetes
October 12, 2026
Aro Biotherapeutics Appoints Biotechnology Executive Brett Blackman, Ph.D., to its Board of Directors
September 29, 2026